We report the development of a method fur diagnosis of heterozygous deletio
ns or duplications based on measurement of gene copy number. The method inv
olves amplifications of a test locus with unknown copy number and a referen
ce locus with known copy number using real-time PCR. Progress of the PCR re
actions is monitored using fluorigenic probes and a real-time fluorescence
detection system. For each reaction, the number of cycles is measured at wh
ich a defined thresh old fluorescence emission is reached. Using standard c
urves, the copy number of the test DNA relative to a common standard DNA is
determined for each locus. From the ratio of the relative copy numbers, th
e genomic copy number of the test locus is determined. In order to demonstr
ate the accuracy and reliability of the method for genetic testing, we anal
yzed 43 patients with hereditary neuropathy with liability to pressure pals
ies (HNPP), containing a heterozygous deletion of a 1.5 Mb region on chromo
some 17p11.2-p12, eight patients with Charcot-Marie-Tooth disease, containi
ng a heterozygous duplication of the same genomic region, and 50 normal con
trol individuals. As a test locus we analyzed the PMP22 gene located within
the 1.5 Mb region. The genomic copy number of the test locus was precisely
measured, and the presence or absence of the genomic deletion or duplicati
on was unambiguously diagnosed in all individuals. Hum Mutat 16:431-436, 20
00. (C) 2000 Wiley-Liss, Inc.